VCEL Vericel Corp Ord

$39.58

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About Vericel Corp Ord

Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cell therapies for the sports medicine and severe burn care markets in the United States. The company is headquartered in Cambridge, Massachusetts.

Website: https://www.vcel.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
887359
Address
64 SIDNEY ST., CAMBRIDGE, MA, US
Valuation
Market Cap
$2.07B
P/E Ratio
206.15
PEG Ratio
0.00
Price to Book
7.08
Performance
EPS
$0.20
Dividend Yield
—
Profit Margin
4.37%
ROE
4.00%
Technicals
50D MA
$48.48
200D MA
$50.06
52W High
$63.00
52W Low
$37.76
Fundamentals
Shares Outstanding
50M
Target Price
$63.75
Beta
1.62

VCEL EPS Estimates vs Actual

● Estimated
● Actual

VCEL News & Sentiment

Nov 20, 2025 • GlobeNewswire NEUTRAL
MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers ...
Nov 14, 2025 • Benzinga NEUTRAL
Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025 - Vericel ( NASDAQ:VCEL )
CAMBRIDGE, Mass., Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Vericel Corporation ( NASDAQ:VCEL ) , a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will participate in a fireside chat at the Stephens Annual Investment Conference at ...
Nov 14, 2025 • GlobeNewswire NEUTRAL
Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025
CAMBRIDGE, Mass., Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Vericel Corporation ( NASDAQ:VCEL ) , a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will participate in a fireside chat at the Stephens Annual Investment Conference at ...
Nov 10, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Wall Street Analysts Believe Vericel ( VCEL ) Could Rally 39.42%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 39.4% in Vericel (VCEL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Nov 06, 2025 • Motley Fool NEUTRAL
Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings
On Tuesday, Baltimore-based Brown Capital Management reported selling 861,020 shares of Vericel Corporation for an estimated $30.9 million based on the average share price in the third quarter.According to a filing with the Securities and Exchange Commission released Tuesday, Brown Capital ...
Nov 06, 2025 • Motley Fool SOMEWHAT-BULLISH
Vericel ( VCEL ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, Nov. 6, 2025, at 8:30 a.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...
Sentiment Snapshot

Average Sentiment Score:

0.130
50 articles with scored sentiment

Overall Sentiment:

Neutral

VCEL Reported Earnings

Jul 31, 2025
Jun 30, 2025 (Pre market)
0.02 Surprise
  • Reported EPS: $-0.01
  • Estimate: $-0.03
  • Whisper: —
  • Surprise %: 66.7%
May 08, 2025
Mar 31, 2025 (Pre market)
-0.08 Surprise
  • Reported EPS: $-0.23
  • Estimate: $-0.15
  • Whisper: —
  • Surprise %: -50.0%
Feb 27, 2025
Dec 31, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.38
  • Estimate: $0.34
  • Whisper: —
  • Surprise %: 11.8%
Nov 07, 2024
Sep 30, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $-0.02
  • Estimate: $-0.05
  • Whisper: —
  • Surprise %: 60.0%
Aug 01, 2024
Jun 30, 2024 (Pre market)
-0.02 Surprise
  • Reported EPS: $-0.10
  • Estimate: $-0.08
  • Whisper: —
  • Surprise %: -25.0%
May 08, 2024
Mar 31, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $-0.08
  • Estimate: $-0.11
  • Whisper: —
  • Surprise %: 27.3%
Feb 29, 2024
Dec 31, 2023 (Pre market)
0.09 Surprise
  • Reported EPS: $0.26
  • Estimate: $0.17
  • Whisper: —
  • Surprise %: 52.9%
Nov 08, 2023
Sep 30, 2023 (Pre market)
0.04 Surprise
  • Reported EPS: $-0.08
  • Estimate: $-0.12
  • Whisper: —
  • Surprise %: 33.3%
Aug 02, 2023
Jun 30, 2023 (Pre market)
0.04 Surprise
  • Reported EPS: $-0.11
  • Estimate: $-0.15
  • Whisper: —
  • Surprise %: 26.7%

Financials